Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Spleen | 4 | 2021 | 877 | 1.85 | Why? |
| Crohn Disease | 9 | 2020 | 959 | 1.34 | Why? |
| Intestinal Diseases | 2 | 2019 | 231 | 1.22 | Why? |
| Celiac Disease | 5 | 2019 | 471 | 1.16 | Why? |
| Internal Medicine | 4 | 2021 | 557 | 1.06 | Why? |
| Endoscopy, Gastrointestinal | 5 | 2021 | 1545 | 0.99 | Why? |
| Gastritis, Atrophic | 3 | 2018 | 20 | 0.95 | Why? |
| Splenic Diseases | 1 | 2021 | 28 | 0.90 | Why? |
| Stomach Ulcer | 2 | 2021 | 101 | 0.86 | Why? |
| Peptic Ulcer Hemorrhage | 1 | 2020 | 24 | 0.86 | Why? |
| Upper Gastrointestinal Tract | 1 | 2020 | 61 | 0.82 | Why? |
| Intestinal Mucosa | 7 | 2019 | 1046 | 0.81 | Why? |
| Postprandial Period | 1 | 2019 | 45 | 0.80 | Why? |
| Peptic Ulcer | 1 | 2020 | 85 | 0.80 | Why? |
| Inflammatory Bowel Diseases | 8 | 2021 | 3209 | 0.80 | Why? |
| Dyspepsia | 1 | 2019 | 60 | 0.77 | Why? |
| Lymphocyte Depletion | 1 | 2020 | 293 | 0.75 | Why? |
| Chromogranin A | 1 | 2018 | 15 | 0.75 | Why? |
| Chimera | 1 | 2018 | 83 | 0.74 | Why? |
| Gastritis | 2 | 2017 | 66 | 0.74 | Why? |
| Pouchitis | 1 | 2018 | 20 | 0.73 | Why? |
| Colitis, Ulcerative | 3 | 2018 | 1037 | 0.73 | Why? |
| Abortion, Habitual | 1 | 2018 | 35 | 0.72 | Why? |
| Gastrointestinal Hemorrhage | 3 | 2021 | 669 | 0.69 | Why? |
| Interleukin-13 | 1 | 2019 | 204 | 0.68 | Why? |
| Diet, Gluten-Free | 1 | 2019 | 185 | 0.68 | Why? |
| Serotonin | 1 | 2018 | 137 | 0.66 | Why? |
| Splenectomy | 1 | 2017 | 85 | 0.66 | Why? |
| Adalimumab | 1 | 2020 | 389 | 0.63 | Why? |
| Enteritis | 1 | 2017 | 147 | 0.62 | Why? |
| Bone Density | 1 | 2019 | 335 | 0.62 | Why? |
| Infertility, Female | 1 | 2018 | 150 | 0.61 | Why? |
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 129 | 0.61 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.54 | Why? |
| Printing, Three-Dimensional | 1 | 2020 | 624 | 0.54 | Why? |
| Gastrointestinal Agents | 1 | 2018 | 393 | 0.53 | Why? |
| Gastrointestinal Tract | 2 | 2021 | 1113 | 0.51 | Why? |
| Migraine Disorders | 1 | 2019 | 530 | 0.47 | Why? |
| Virion | 1 | 2020 | 1444 | 0.46 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.46 | Why? |
| Gastrointestinal Diseases | 5 | 2021 | 2580 | 0.45 | Why? |
| Eosinophils | 1 | 2017 | 848 | 0.43 | Why? |
| Lymphocyte Subsets | 1 | 2017 | 987 | 0.42 | Why? |
| T-Box Domain Proteins | 1 | 2009 | 62 | 0.40 | Why? |
| Calcium Channels | 1 | 2009 | 96 | 0.38 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 1454 | 0.38 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.37 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.36 | Why? |
| Gastrointestinal Microbiome | 2 | 2021 | 1961 | 0.36 | Why? |
| Myofibroblasts | 2 | 2018 | 61 | 0.36 | Why? |
| Autoimmune Diseases | 3 | 2018 | 1996 | 0.35 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.35 | Why? |
| Vaccination Coverage | 1 | 2017 | 1249 | 0.35 | Why? |
| Intestinal Neoplasms | 2 | 2017 | 42 | 0.34 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.34 | Why? |
| Extracellular Matrix | 2 | 2018 | 189 | 0.33 | Why? |
| Ultrasonography | 2 | 2020 | 4409 | 0.32 | Why? |
| Frailty | 1 | 2018 | 1432 | 0.31 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.31 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.30 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.30 | Why? |
| Biological Therapy | 2 | 2021 | 456 | 0.29 | Why? |
| Venous Thromboembolism | 2 | 2020 | 4273 | 0.29 | Why? |
| Carcinoma | 2 | 2017 | 256 | 0.27 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.25 | Why? |
| Liver Diseases | 2 | 2021 | 2698 | 0.24 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.24 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.23 | Why? |
| T-Lymphocyte Subsets | 1 | 2009 | 1387 | 0.22 | Why? |
| Aging | 1 | 2018 | 3581 | 0.22 | Why? |
| Italy | 13 | 2021 | 38444 | 0.22 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.22 | Why? |
| Humans | 54 | 2021 | 930598 | 0.22 | Why? |
| Hospital Mortality | 4 | 2020 | 22087 | 0.22 | Why? |
| Stomach | 1 | 2021 | 141 | 0.21 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.21 | Why? |
| Erythrocyte Count | 1 | 2021 | 137 | 0.21 | Why? |
| Procollagen | 1 | 2019 | 29 | 0.20 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.20 | Why? |
| Gastric Mucosa | 1 | 2021 | 141 | 0.20 | Why? |
| Osteoprotegerin | 1 | 2019 | 32 | 0.20 | Why? |
| Fibrosis | 3 | 2018 | 800 | 0.20 | Why? |
| Cellular Microenvironment | 1 | 2018 | 55 | 0.19 | Why? |
| Bone Diseases, Metabolic | 1 | 2019 | 64 | 0.19 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.19 | Why? |
| Colonic Pouches | 1 | 2018 | 17 | 0.19 | Why? |
| B-Lymphocyte Subsets | 1 | 2020 | 372 | 0.19 | Why? |
| Gelatinases | 1 | 2018 | 7 | 0.19 | Why? |
| Anemia, Iron-Deficiency | 1 | 2021 | 210 | 0.18 | Why? |
| Transforming Growth Factor beta1 | 2 | 2017 | 204 | 0.18 | Why? |
| Proctocolectomy, Restorative | 1 | 2018 | 51 | 0.18 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2019 | 100 | 0.18 | Why? |
| Masks | 1 | 2020 | 8528 | 0.17 | Why? |
| Biological Factors | 1 | 2021 | 276 | 0.17 | Why? |
| Smad7 Protein | 1 | 2017 | 32 | 0.17 | Why? |
| Chemokine CCL20 | 1 | 2017 | 47 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.17 | Why? |
| Natural Killer T-Cells | 1 | 2019 | 191 | 0.17 | Why? |
| Liver Failure | 1 | 2020 | 266 | 0.16 | Why? |
| Aged | 21 | 2021 | 215776 | 0.16 | Why? |
| Vitamin B 12 | 1 | 2018 | 132 | 0.16 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.16 | Why? |
| Oligonucleotides | 1 | 2017 | 137 | 0.16 | Why? |
| Ileum | 1 | 2018 | 233 | 0.16 | Why? |
| Adult | 21 | 2021 | 244371 | 0.15 | Why? |
| Female | 25 | 2021 | 380317 | 0.15 | Why? |
| Male | 26 | 2021 | 367725 | 0.15 | Why? |
| Cancer Vaccines | 1 | 2017 | 136 | 0.15 | Why? |
| Collagen Type III | 1 | 2014 | 12 | 0.15 | Why? |
| Promoter Regions, Genetic | 1 | 2019 | 823 | 0.15 | Why? |
| Th2 Cells | 1 | 2019 | 680 | 0.14 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.14 | Why? |
| Neuroendocrine Tumors | 1 | 2018 | 241 | 0.14 | Why? |
| Collagen Type I | 1 | 2014 | 56 | 0.14 | Why? |
| Cell Line, Tumor | 2 | 2017 | 3608 | 0.14 | Why? |
| Hemoglobins | 1 | 2021 | 958 | 0.14 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.14 | Why? |
| Anemia | 2 | 2021 | 789 | 0.14 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.14 | Why? |
| Infliximab | 1 | 2018 | 502 | 0.13 | Why? |
| Osteoporosis | 1 | 2019 | 410 | 0.13 | Why? |
| Helicobacter pylori | 1 | 2016 | 262 | 0.13 | Why? |
| Multimorbidity | 1 | 2018 | 703 | 0.13 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.13 | Why? |
| Epstein-Barr Virus Infections | 1 | 2017 | 366 | 0.12 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2020 | 1061 | 0.12 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 552 | 0.12 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.12 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.12 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.12 | Why? |
| Neurodegenerative Diseases | 1 | 2018 | 469 | 0.11 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Aged, 80 and over | 9 | 2020 | 88759 | 0.11 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.11 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.10 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.10 | Why? |
| Patch-Clamp Techniques | 1 | 2009 | 49 | 0.10 | Why? |
| Organ Culture Techniques | 1 | 2009 | 119 | 0.10 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.10 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.10 | Why? |
| Jurkat Cells | 1 | 2009 | 273 | 0.10 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Peptide Fragments | 1 | 2019 | 2075 | 0.09 | Why? |
| Tertiary Care Centers | 3 | 2020 | 8248 | 0.09 | Why? |
| Biomarkers | 4 | 2020 | 23361 | 0.09 | Why? |
| Vitamin D | 2 | 2020 | 2904 | 0.09 | Why? |
| Animals | 5 | 2021 | 78931 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Longitudinal Studies | 2 | 2020 | 9893 | 0.09 | Why? |
| Dietary Supplements | 1 | 2020 | 2251 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.08 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.08 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.08 | Why? |
| Cytokines | 1 | 2009 | 15010 | 0.08 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.08 | Why? |
| Endoscopy | 1 | 2017 | 1564 | 0.08 | Why? |
| Calcium Channel Blockers | 1 | 2009 | 367 | 0.08 | Why? |
| Lymphocytes | 1 | 2019 | 3056 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.08 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2017 | 2262 | 0.08 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Constriction, Pathologic | 2 | 2018 | 212 | 0.07 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.07 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2018 | 3803 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2019 | 4027 | 0.07 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.07 | Why? |
| Registries | 3 | 2018 | 12327 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.06 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.06 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.06 | Why? |
| Trust | 1 | 2014 | 1487 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.06 | Why? |
| Primary Health Care | 1 | 2021 | 4839 | 0.06 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.06 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.06 | Why? |
| Blood Gas Monitoring, Transcutaneous | 1 | 2021 | 52 | 0.06 | Why? |
| Rats | 1 | 2009 | 2764 | 0.06 | Why? |
| Cholinesterases | 1 | 2021 | 48 | 0.06 | Why? |
| Enteric Nervous System | 1 | 2021 | 28 | 0.06 | Why? |
| Lung | 2 | 2020 | 31049 | 0.06 | Why? |
| MicroRNAs | 1 | 2014 | 1787 | 0.06 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.05 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.05 | Why? |
| Sitagliptin Phosphate | 1 | 2020 | 82 | 0.05 | Why? |
| Whey Proteins | 1 | 2020 | 59 | 0.05 | Why? |
| Duodenum | 1 | 2021 | 179 | 0.05 | Why? |
| Colitis, Ischemic | 1 | 2021 | 116 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.05 | Why? |
| Hospitalization | 5 | 2020 | 54280 | 0.05 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2019 | 116 | 0.05 | Why? |
| Mice | 1 | 2019 | 21357 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2021 | 508 | 0.05 | Why? |
| Health Services Needs and Demand | 1 | 2014 | 3419 | 0.05 | Why? |
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2018 | 33 | 0.05 | Why? |
| Pancreatic Diseases | 1 | 2021 | 191 | 0.04 | Why? |
| Colitis | 1 | 2021 | 266 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 43 | 0.04 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.04 | Why? |
| Microsatellite Instability | 1 | 2017 | 57 | 0.04 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 100 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Endopeptidases | 1 | 2018 | 228 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2019 | 360 | 0.04 | Why? |
| Atrophy | 1 | 2016 | 192 | 0.04 | Why? |
| Collagen | 1 | 2018 | 222 | 0.04 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 179 | 0.04 | Why? |
| Receptor, ErbB-2 | 1 | 2017 | 267 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.04 | Why? |
| Dysbiosis | 1 | 2021 | 685 | 0.04 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Gene Frequency | 1 | 2019 | 1210 | 0.03 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.03 | Why? |
| Herpesvirus 4, Human | 1 | 2017 | 387 | 0.03 | Why? |
| Helicobacter Infections | 1 | 2016 | 216 | 0.03 | Why? |
| Wound Healing | 1 | 2018 | 424 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.02 | Why? |
| Diarrhea | 1 | 2021 | 2743 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Down-Regulation | 1 | 2014 | 1416 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Genotype | 1 | 2019 | 4697 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Up-Regulation | 1 | 2014 | 2249 | 0.02 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Liver | 1 | 2020 | 4007 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Serine Endopeptidases | 1 | 2018 | 4606 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |